CIK 0001869105
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-702-0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
Page 2 of 2 · 32 filings